Europe PCR Multiplex Assays Market – Industry Trends - Forecast to 2026

  • Medical Devices
  • Published Report
  • Jun 2019
  • Europe
  • 350 Pages
  • No of Tables: 22
  • No of Figures: 75

Europe PCR Multiplex Assays Market By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Country (Germany, France, U.K., Italy, Spain, Ireland, Austria, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends & Forecast to 2026

Multiplex assays are the new technology which is incorporated with the capability to run more than one target sequence in a single step, the evolution of the PCR multiplex assays in terms of smart features with voice command, facial authentication and radio-frequency identification (RFID) features changes from an manual instrument to an automated PCR multiplexes systems in the year 2016 to 2018.

Multiplex assay can amplify more than one target sequence with the help of multiple primer pairs in reaction mixtures. The PCR technique is a time saving with significant less efforts in the laboratory experiments, which is a convenient and rapid screening assay for clinical and research laboratories. The PCR multiplex assay manufactures to expand their business for the development of services. For instance In June 2018, QIAGEN announced the launch of QIAseq 16S Panels and UCP Multiplex PCR kit which enables in the profiling of complex microbiome samples. The new products reduce the profiling bias and a kit is featured with the nucleic acid-depleted reagents which are tested for the fungal and bacterial DNA contamination. QIAseq 16S Panels enhances robust profiling with the flexibility and interrogates of fungal ITS regions and bacterial 16S variable regions on Illumina platforms. The product is designed with unbiased microbiome profiling and helping scientists to avoid external biased obstacle. The introduction of product helps clinicians in microbial profiling and expanded the advanced product portfolio of the company.

Europe PCR multiplex assays market is projected to register a substantial CAGR in the forecast period 2019 to 2026.

Segmentation: Europe PCR Multiplex Assays Market

Europe PCR multiplex assays market is segmented into three notable segments which are products & services, application and end user.

  • On the basis of products & services, the market is segmented into reagents & consumables, instruments & accessories and software and services.
  • On the basis of application, the market is segmented into research & development and clinical diagnostics.
  • On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.

Competitive Analysis: Europe PCR Multiplex Assays Market

Some of the major players operating in this market are HOL0GIC INC, LUMINEX CORPORATION., BECTON, DICKINSON AND COMPANY, ABBOTT, Thermo Fisher Scientific Inc, QIAGEN, Agilent Technologies Inc, Meso Scale Diagnostics, LLC, Randox Laboratories Ltd., Bio-Techne, Seegene Inc., Olink, Illumina, Inc, Bio-Rad Laboratories, Inc,  Abcam Plc, Quanterix, Sysmex Corporation, Siemens, Diasorin, Quest Diagnostics Incorporated, PerkinElmer Inc, Eurofins Scientific, Agena Bioscience, Inc, F. Hoffmann-La Roche Ltd, among others.

Recent Developments:

  • In January 2018, Hologic, Inc. announced the winning of award of Prequalification by its product Aptima HIV-1 Quant Dx by the World Health Organization (WHO). This award symbolizes that the product meets all the necessary requirements of the FDA. The recognition of milestone award helps company to develop advanced treatment for HIV infections around world.

  • In July 2016, Luminex Corporation announced that they have received FDA approval and CE-IVD marking for their product ARIES M1 System. The product is designed for lower throughput clinical laboratories. The approval enhances the product portfolio based on customer’s feedback leading to the expansion in the market.

  • In October 2015, Luminex Corporation announced that FDA approval of ARIES System and ARIES HSV 1&2 Assay, which is designed to increase the efficiency of the laboratory by providing accurate results of tests. The launch of the product enhances the market potential to cover around 6,500 hospital labs and 13 fold increase the customers in the U.S.

Research Methodology: Europe PCR Multiplex Assays Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

LIST OF TABLES EUROPE PCR MULTIPLEX ASSAYS MARKET

TABLE 1 RESEARCH AND DEVELOPMENT ACTIVITIES OF MAJOR BIO-PHARMA COMPANIES TABLE 2 LIST OF HUMAN GENETIC TESTS TABLE 3 THE COST OF THE FEW REAGENT USED IN THE PCR MULTIPLEX ASSAYS ARE; TABLE 4 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 5 EUROPE REAGENTS & CONSUMABLES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 6 EUROPE INSTRUMENTS & ACCESSORIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 7 EUROPE SOFTWARE AND SERVICES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 9 EUROPE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 10 EUROPE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 11 EUROPE RESEARCH & DEVELOPMENT IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 12 EUROPE RESEARCH & DEVELOPMENT IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 13 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 14 EUROPE HOSPITALS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 EUROPE CLINICAL LABORATORIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 17 EUROPE RESEARCH INSTITUTES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 18 EUROPE OTHERS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 19 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 20 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 21 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 22 EUROPE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 23 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 24 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 25 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 26 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 27 GERMANY CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 28 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 29 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 30 U.K. PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 31 U.K. PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 32 U.K. CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 33 U.K. PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 34 U.K. PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 35 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 36 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 37 FRANCE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 38 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 39 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 40 ITALY PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 41 ITALY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 42 ITALY CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 43 ITALY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 44 ITALY PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 45 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 46 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 47 SPAIN CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 48 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 49 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 50 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 51 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 52 SWITZERLAND CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 53 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 54 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 55 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 56 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 57 NETHERLANDS CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 58 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 59 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 60 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 61 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 62 BELGIUM CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 63 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 64 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 65 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 66 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 67 AUSTRIA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 68 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 69 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 70 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION) TABLE 71 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 72 IRELAND CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 73 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION) TABLE 74 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 75 REST OF EUROPE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICE, 2017-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE